Difficulty: Medium
Average Score: 75%
Practice
A 58-year-old woman with multiple sclerosis presents to her primary care physician for follow-up. She ambulates well and has few issues with her disease. Which of the following agents may be beneficial in slowing the progression of this disease?
Correct answer
B
Rationale
In the case of a 58-year-old woman with multiple sclerosis, the correct answer is B) Fingolimod. Fingolimod is a disease-modifying therapy that has shown efficacy in reducing relapses and slowing disease progression in multiple sclerosis patients. It works by trapping immune cells in the lymph nodes, preventing them from entering the central nervous system and causing damage.
Option A) Dalfampridine is indicated for improving walking in patients with MS but does not slow disease progression. Option C) Mitoxantrone is a chemotherapy agent with significant toxicities and is generally reserved for severe, progressive forms of MS due to its risks. Option D) Vitamin A has no established role in the treatment of multiple sclerosis.
Educationally, this question highlights the importance of understanding the mechanism of action and appropriate use of CNS drugs in managing neurological conditions like multiple sclerosis. It emphasizes the need for selecting therapies based on their efficacy, safety profile, and impact on disease progression to provide optimal care for patients.
Option A) Dalfampridine is indicated for improving walking in patients with MS but does not slow disease progression. Option C) Mitoxantrone is a chemotherapy agent with significant toxicities and is generally reserved for severe, progressive forms of MS due to its risks. Option D) Vitamin A has no established role in the treatment of multiple sclerosis.
Educationally, this question highlights the importance of understanding the mechanism of action and appropriate use of CNS drugs in managing neurological conditions like multiple sclerosis. It emphasizes the need for selecting therapies based on their efficacy, safety profile, and impact on disease progression to provide optimal care for patients.